Introduction Diabetic ketoacidosis is a life-threatening condition that requires prompt management. Objectives We aimed to assess the impact of adherence to potassium replacement protocol according to ...
Use of sodium-glucose co-transporter 2 (SGLT-2) inhibitors is currently classified as off-label in individuals less than 18 years of age in Canada. Use of SGLT-2 inhibitors may result in euglycemic ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Alternative, patient-tailored strategies ...
The incidence of diabetic ketoacidosis in patients with type 2 diabetes taking an SGLT2 inhibitor is no greater than the low levels occurring in the general diabetes population, according to a joint ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback